Clinical Trial

The Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer Patients

Completed Phase 2
View on ClinicalTrials.gov →
Summary
the study aims to evaluate the cardioprotective effect of atorvastatin in breast cancer female patients treated with doxorubicin based chemotherapy
Trial Details
NCT Number NCT07668076
Lead Sponsor Damanhour University
Conditions Breast Cancer, Doxorubicin Induced Cardiomyopathy
Enrollment 44 participants
Start Date 2022-11-15
Primary Completion 2024-10-20 (estimated)
Study Completion 2024-10-20 (estimated)
Updated on ClinicalTrials.gov 2026-06-25